Assessment of Factors Affecting Therapeutic Response of the DPP-4 Inhibitor Sitagliptin in A Sample of Iraqi Type 2 Diabetic Patients. AJPS. 2024;24(3):311-319. doi:10.32947/ajps.v24i3.1082